Drug Trial Radar · NCT07133802
Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination
Last checked: Nov 20, 2026Latest source record: Aug 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
6,680
Planned (sponsor's estimate)
Start
Aug 2025
Primary completion
Mar 2026
Study completion Jul 2026
Sponsor
- Lead sponsor
- Changchun BCHT Biotechnology Co.Industry
- Sponsor type
- Industry
- Collaborators
- Hebei Provincial Center for Disease Control and Prevention; Center for Disease Control and Prevention, Fujian; Zhejiang Provincial Center for Disease Control and Prevention
- First posted
- Aug 21, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 59 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination
Conditions
- Prevention of Influenza
Interventions
Placebo GroupBiological
Each human dose: 0.2 mL
Test GroupBiological
Each human dose is 0.2 mL
Primary outcomes
What the sponsor says the trial is designed to measure.
- Protective EfficacyTime frame: at 14 days post-vaccination
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.